"Although [adenovirus-based] COVID-19 vaccines are out of the picture... an adenovirus-based Ebola shot is on the market, and similar vaccines against other diseases are in development. The new data suggest they, too, could cause VITT, but they might be made safer by tinkering with the adenovirus."
